Iguana Biotec Revenue

Biotechnology Research • Munich, Bavaria, Germany • 1-10 Employees

Iguana Biotec revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Iguana Biotec

Hassan Moeini

Director of Research & Development

Company overview

Headquarters	Sendlingerstasse 60, Munich, Bavaria 80331, DE
Phone number	+491622698171
Website	iguana-biotec.com
NAICS	541714
Keywords	Biotechnology, Life Science, Pharmaceuticals, Vaccines, Start Up, Cancer Prevention, Ulcers, Vaccine Development, Helicobacter Pylori, Krebsvorsorge, Therapeutic Vaccines, Gastric Cancer, H. Pylori, Stomach Ulcers, Stomach Diseases, Epitopes, Innovative Vaccines, Malt Lymphoma, Antibiotic Alternativ, Antibiotica Alternativen, Antibiotica Forschung, Fighting Stomach Cancer, Forschung Impfstoff, Innovations Biotechnology, Innovative Start-Ups, Trends Pharma
Founded	2021
Employees	1-10

Iguana Biotec Email Formats

Iguana Biotec uses 1 email format. The most common is {2char} (e.g., {2char}@iguana-biotec.com), used 100% of the time.

Format	Example	Percentage
{2char}	{2char}@iguana-biotec.com	100%

About Iguana Biotec

Iguana Biotechnology GmbH (Iguana), an innovative BioTech start-up based in Munich, Germany, is pursuing as lead candidate the development of a therapeutic vaccine against Helicobacter pylori, one of the most common infectious diseases worldwide. Currently, about 50% of the world's population is affected by this infection. Early diagnosis and treatment of the infection can significantly reduce the risk of serious gastric diseases such as gastric ulcers, MALT lymphoma and gastric cancer. Due to increasing resistance to conventional antibiotic therapy, the development of effective therapeutic alternatives is essential. Iguana's innovative approach to a therapeutic vaccine meets the urgent need for a therapeutic alternative and to increase the prevention of gastric cancer.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Iguana Biotec has never raised funding before.

Iguana Biotec Tech Stack

Discover the technologies and tools that power Iguana Biotec's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Squarespace

CMS

Cart Functionality

Ecommerce

YUI

JavaScript libraries

Strato

Hosting

Frequently asked questions

Iguana Biotec is located in Munich, Bavaria, DE.

You can reach Iguana Biotec at +491622698171.

Iguana Biotec generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Iguana Biotec has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Iguana Biotec was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Iguana Biotec has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Iguana Biotec

Hassan Moeini

Director of Research & Development

4.8

40,000 users